Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart FailureJoão Pedro Ferreira, Milton Packer, Javed Butler et al.|Journal of the American College of Cardiology|2021Cited by 164
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trialPK Judge, A. Q. Adeleke, Natalie Staplin et al.|The Lancet Diabetes & Endocrinology|2023Cited by 107